These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30171979)

  • 21. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
    Ghori MU; Ginting G; Smith AM; Conway BR
    Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An oral-controlled release drug delivery system for liquid and semisolid drug formulations.
    Haznar-Garbacz D; Garbacz G; Eisenächer F; Klein S; Weitschies W
    AAPS PharmSciTech; 2011 Dec; 12(4):1183-5. PubMed ID: 21918919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tablets with material gradients fabricated by three-dimensional printing.
    Yu DG; Yang XL; Huang WD; Liu J; Wang YG; Xu H
    J Pharm Sci; 2007 Sep; 96(9):2446-56. PubMed ID: 17497729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study on the release mechanism of drugs from hydrophilic partially coated perforated matrices.
    Sangalli ME; Maroni A; Zema L; Cerea M; Conte U; Gazzaniga A
    Farmaco; 2003 Sep; 58(9):971-6. PubMed ID: 13679193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of synthetic and semisynthetic polymers (Kollidon K30 and hydroxypropylmethylcellulose) as carriers of ketoprofen in solid oral prolonged-release dosage forms].
    Linka W; Kot M; Kołodziejczyk M
    Polim Med; 2016; 46(2):145-153. PubMed ID: 28397455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FORMULATION, EVALUATION AND IN VITRO DISSOLUTION PERFORMANCE OF ENALAPRIL MALEATE SUSTAINED RELEASE MATRICES: EFFECT OF POLYMER COMPOSITION AND VISCOSITY GRADE.
    Shah A; Khan GM; Ullah H; Khan KA; Ullah K; Khan SA
    Acta Pol Pharm; 2016 Jul; 73(4):1037-1043. PubMed ID: 29648730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between surface free energy, surface texture parameters and controlled drug release in hydrophilic matrices.
    Saurí J; Suñé-Negre JM; Díaz-Marcos J; Vilana J; Millán D; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2015 Jan; 478(1):328-340. PubMed ID: 25433200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of formulation factors on the moist granulation technique for controlled-release tablets.
    Railkar AM; Schwartz JB
    Drug Dev Ind Pharm; 2001 Oct; 27(9):893-8. PubMed ID: 11763466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery.
    Pillay V; Fassihi R
    J Pharm Sci; 1999 Nov; 88(11):1140-8. PubMed ID: 10564062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel drug delivery devices for providing linear release profiles fabricated by 3DP.
    Yu DG; Branford-White C; Ma ZH; Zhu LM; Li XY; Yang XL
    Int J Pharm; 2009 Mar; 370(1-2):160-6. PubMed ID: 19118612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.
    Kubova K; Peček D; Hasserová K; Doležel P; Pavelková M; Vyslouzil J; Muselík J; Vetchy D
    Pharm Dev Technol; 2017 Mar; 22(2):206-217. PubMed ID: 28058866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.
    Mašková E; Kubová K; Vysloužil J; Pavloková S; Vetchý D
    AAPS PharmSciTech; 2017 May; 18(4):1242-1253. PubMed ID: 27474035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
    Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modern polymers in matrix tablets technology].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(3):189-96. PubMed ID: 25739125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets.
    Mitchell SA; Balwinski KM
    Drug Dev Ind Pharm; 2007 Sep; 33(9):952-8. PubMed ID: 17891581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.